These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20603612)

  • 1. Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.
    Das PM; Thor AD; Edgerton SM; Barry SK; Chen DF; Jones FE
    Oncogene; 2010 Sep; 29(37):5214-9. PubMed ID: 20603612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.
    Shao B; Feng Y; Zhang H; Yu F; Li Q; Tan C; Xu H; Ying J; Li L; Yang D; Peng W; Tang J; Li S; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2018 Feb; 22(2):1257-1271. PubMed ID: 29193730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
    Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
    Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.
    Lubecka K; Kaufman-Szymczyk A; Cebula-Obrzut B; Smolewski P; Szemraj J; Fabianowska-Majewska K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
    Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
    Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
    Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
    Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
    Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
    BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.
    Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN
    Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic unmasking of epigenetically silenced genes in breast cancer.
    Ostrow KL; Park HL; Hoque MO; Kim MS; Liu J; Argani P; Westra W; Van Criekinge W; Sidransky D
    Clin Cancer Res; 2009 Feb; 15(4):1184-91. PubMed ID: 19228724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
    Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.
    Wolf I; Bose S; Desmond JC; Lin BT; Williamson EA; Karlan BY; Koeffler HP
    Breast Cancer Res Treat; 2007 Oct; 105(2):139-55. PubMed ID: 17295047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.